Discover 889 paid clinical trials in Birmingham, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 889
Active & Responsive
Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment
for
Non-small Cell Lung Cancer
Location: Birmingham AL, Elizabethtown KY, Tampa FL, New York NY
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06841055
Phase2, Recruiting
Active & Responsive
UAB Alzheimer's Disease Center Core Cohort - Imaging Substudy
for
Alzheimer Disease
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 50+
Code: NCT03503331
Phase2, Recruiting
Active & Responsive
Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome
for
Cascade Testing, Lynch Syndrome, Decision Making,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18+
Code: NCT07106359
Recruiting
Active & Responsive
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer,
Location: Birmingham AL, Atlanta GA, Nashville TN, Knoxville TN,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT06901531
Phase3, Recruiting
Active & Responsive
Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
for
Type I Diabetes
Location: Birmingham AL, Chicago IL, Aurora CO, Walnut Creek CA,
Sponsor: Op-T LLC
Sex: All
Age: 18 - 50
Code: NCT06964087
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
for
Neuroblastoma, Sarcoma
Location: Birmingham AL, Columbus OH, Washington D.C. DC,
Sponsor: Nationwide Children's Hospital
Sex: All
Age: 1 - 40
Code: NCT05135975
Phase2, Recruiting
Active & Responsive
Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease
for
Fabry Disease
Location: Birmingham AL, Atlanta GA, Chicago IL, Pittsburgh PA,
Sponsor: UniQure Biopharma B.V.
Sex: Male
Age: 18 - 50
Code: NCT06270316
Phase1, Phase2, Recruiting
Active & Responsive
Multisite Implementation of COMPRENDO
for
Pediatric Cancer
Location: Birmingham AL, Boston MA, San Diego CA,
Sponsor: University of California, San Diego
Sex: All
Age: 18+
Code: NCT06055296
Recruiting
Active & Responsive
Evaluation of Accuracy of the Owlet OSS 3.0 Sensor in the Neonatal Population
for
Pulse Oximeter Validation
Location: Birmingham AL, Minneapolis MN
Sponsor: Owlet Baby Care, Inc.
Sex: All
Age: 0
Code: NCT06771206
Recruiting
Active & Responsive
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
for
Pleuropulmonary Blastoma
Location: Birmingham AL, Atlanta GA, Nashville TN, Pensacola FL,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT06647953
Phase3, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer